1 |
hepatitis C virus
(39693 times)
|
Gastroenterology (8796 times)
|
HBV (3993 times) HCC (2885 times) SVR (2767 times)
|
1989 [Post-transfusion non-A, non-B hepatitis: is a specific test in sight?].
|
2 |
hepatitis C virus infection
(220 times)
|
Gastroenterology (50 times)
|
HCC (20 times) IFN (17 times) SVR (17 times)
|
1993 [How many patients with chronic viral hepatitis qualify for interferon therapy? Prospective analysis of university ambulatory care].
|
3 |
HCVcc
(125 times)
|
Virology (47 times)
|
HCVpp (30 times) SR-BI (10 times) siRNA (7 times)
|
2006 Hepatitis C virus entry: potential receptors and their biological functions.
|
4 |
hog cholera virus
(96 times)
|
Veterinary Medicine (44 times)
|
BVDV (29 times) BDV (9 times) mAbs (9 times)
|
1968 The purification and concentration of hog cholera virus.
|
5 |
hippocampal volume
(34 times)
|
Neurology (16 times)
|
MRI (9 times) AD (6 times) MCI (6 times)
|
1997 11C-flumazenil PET, volumetric MRI, and quantitative pathology in mesial temporal lobe epilepsy.
|
6 |
human coronavirus
(32 times)
|
Virology (17 times)
|
BCV (5 times) HEV (4 times) HI (3 times)
|
1981 Two antigenic groups of human coronaviruses detected by using enzyme-linked immunosorbent assay.
|
7 |
HCV-Ab
(7 times)
|
Gastroenterology (2 times)
|
HBsAg (2 times) HIV (2 times) ART (1 time)
|
1996 [Familial transmission of hepatitis C virus].
|
8 |
human calicivirus
(6 times)
|
Microbiology (3 times)
|
ELISA (1 time) ELISAs (1 time) IEM (1 time)
|
1985 Humoral immunity in infants with gastroenteritis caused by human calicivirus.
|
9 |
hepatitis C virus antibody
(5 times)
|
Medicine (2 times)
|
CHD (1 time) CV (1 time) CVD (1 time)
|
1990 [Hepatitis C virus antibodies (HCV) in patients treated with chronic hemodialysis].
|
10 |
high conservation value
(4 times)
|
Environmental Health (2 times)
|
HCS (1 time) IPA (1 time) IUCN (1 time)
|
2015 Taking high conservation value from forests to freshwaters.
|
11 |
HC virus
(3 times)
|
Veterinary Medicine (2 times)
|
HC (2 times) BVDV (1 time) HCC (1 time)
|
1976 Natural infection of pigs with bovine viral diarrhea virus and its differential diagnosis from hog cholera.
|
12 |
HCV infection
(3 times)
|
Biomedical Research (1 time)
|
alpha-IFN (1 time) SHF (1 time) TBARS (1 time)
|
2001 [Cryoglobulinemia and hepatitis C virus infection].
|
13 |
hepacivirus
(3 times)
|
Chemistry (1 time)
|
dsRNA (1 time)
|
2007 Status Presens of Antiviral Drugs And Strategies: Part I: DNA Viruses and Retroviruses.
|
14 |
hepatitis C virus genome
(3 times)
|
Cell Biology (1 time)
|
RFLP (1 time)
|
1996 Improved amplification system for detection of hepatitis C virus genome that simultaneously differentiates viral genotypes.
|
15 |
hepatitis virus type C
(3 times)
|
Medicine (1 time)
|
CH (1 time) DM (1 time) HBs (1 time)
|
1994 A seroepidemiological study of hepatitis C virus (HCV) in an area with a high prevalence of chronic liver disease in the Kyushu district of Japan.
|
16 |
HIV-hepatitis C
(3 times)
|
Patient Compliance (1 time)
|
DAA (1 time) HIV (1 time) IL-10 (1 time)
|
2010 Gender differences in clinical, immunological, and virological outcomes in highly active antiretroviral-treated HIV-HCV coinfected patients.
|
17 |
HCV group
(2 times)
|
Gastroenterology (1 time)
|
HBV (2 times) HCC (2 times) AFP (1 time)
|
2007 Significance of hepatitis B virus surface antigen, hepatitis C virus expression in hepatocellular carcinoma and pericarcinomatous tissues.
|
18 |
HCV-positive group
(2 times)
|
Tooth Diseases (1 time)
|
OLP (2 times) ICC (1 time)
|
2006 Clinicopathologic characteristics of hepatitis C virus-associated intrahepatic cholangiocarcinoma.
|
19 |
HCVser
(2 times)
|
Clinical Laboratory Techniques (1 time)
|
HLCs (1 time) iPSCs (1 time) MSCs (1 time)
|
2011 Intracellular delivery of serum-derived hepatitis C virus.
|
20 |
hepatitis C virus chronic infection
(2 times)
|
Allergy and Immunology (2 times)
|
AT (1 time) HCVrA (1 time) IMO (1 time)
|
2008 High values of CXCL10 serum levels in patients with hepatitis C associated mixed cryoglobulinemia in presence or absence of autoimmune thyroiditis.
|
21 |
hepatitis C virus core protein
(2 times)
|
Botany (1 time)
|
FBN (1 time) GQD-SH (1 time) PG (1 time)
|
2012 Dual targeting of a mature plastoglobulin/fibrillin fusion protein to chloroplast plastoglobules and thylakoids in transplastomic tobacco plants.
|
22 |
hepatitis C virus-positive
(2 times)
|
Epidemiology (1 time)
|
CLD (1 time) HR (1 time) PEG-IFN (1 time)
|
1998 Systematic cutaneous examination in hepatitis C virus infected patients.
|
23 |
hepatitis type-C virus
(2 times)
|
Genetics (1 time)
|
CI (1 time) HRM (1 time) OR (1 time)
|
2015 Identification of mutations in the HVR1 and PKR-BD regions in HCV-infected patients resistant to PEG-IFNalpha/RBV therapy.
|
24 |
high-cholesterol plus vitamins C+E
(2 times)
|
Vascular Diseases (2 times)
|
HC (2 times) NC (2 times) LDL (1 time)
|
2001 Vitamins C and E attenuate plasminogen activator inhibitor-1 (PAI-1) expression in a hypercholesterolemic porcine model of angioplasty.
|
25 |
human chromosome vector
(2 times)
|
Genetics (2 times)
|
---
|
2001 Efficient male and female germline transmission of a human chromosomal vector in mice.
|
26 |
hybrid cooling vest
(2 times)
|
|
PAS (1 time) PCMs (1 time) PeSA (1 time)
|
2016 Hybrid cooling vest for cooling between exercise bouts in the heat: Effects and practical considerations.
|
27 |
anti-HCV
(1 time)
|
Gastroenterology (1 time)
|
AIH (1 time) AMA (1 time) ANA (1 time)
|
1997 A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
|
28 |
Anti-hepatitis C virus positivity
(1 time)
|
Medicine (1 time)
|
---
|
1995 Anti-hepatitis C virus positivity (HCV) in Belgian volunteer blood donors: source of contamination and HCV-testing among donors and related recipients.
|
29 |
betweenhepatitis C virus
(1 time)
|
|
CT (1 time) DNA (1 time) HBV (1 time)
|
2020 A Rare Case of Hepatic Sarcoidosis Caused By Hepatitis B Virus and Treatment-Induced Opportunistic Infection.
|
30 |
challenge-hepatitis C virus
(1 time)
|
Health Services Research (1 time)
|
VA (1 time)
|
2019 The health equity implementation framework: proposal and preliminary study of hepatitis C virus treatment.
|
31 |
chronic C virus
(1 time)
|
Medicine (1 time)
|
GGT (1 time) IFN (1 time)
|
2000 [Therapy of chronic hepatitis C with alpha-interferon in 182 patients. Evaluation of results, response predictive factors and side effects].
|
32 |
Flaviviridae-hepatitis C virus
(1 time)
|
Epidemiology (1 time)
|
HIV (1 time) IVDU (1 time)
|
2002 HCV and GBV-c/HGV infection in HIV positive patients in southern Italy.
|
33 |
had comorbid viral hepatitis C
(1 time)
|
Neurology (1 time)
|
---
|
2022 [The structure of stroke and the effect of somatic and addiction diseases on its appearance and course in patients with HIV infection].
|
34 |
had pretransplant samples available for antihepatitis C virus
(1 time)
|
Transplantation (1 time)
|
VOD (1 time)
|
1991 Hepatic veno-occlusive disease post-bone marrow transplantation in children conditioned with busulfan and cyclophosphamide: incidence, risk factors, and clinical outcome.
|
35 |
had raised transaminases and positive antihepatitis C virus
(1 time)
|
Pediatrics (1 time)
|
---
|
1996 Lymphoblastoid interferon alfa treatment in chronic hepatitis C.
|
36 |
half-dose sofosbuvir in patients with acute infection withhepatitis C virus
(1 time)
|
Nephrology (1 time)
|
eGFR (1 time)
|
2020 Acute hepatitis C treatment in advanced renal failure using 8 weeks of pan-genotypic daclatasvir and reduced-dose sofosbuvir.
|
37 |
has made antihepatitis C virus
(1 time)
|
Gastroenterology (1 time)
|
DAAs (1 time) NS (1 time) RAVs (1 time)
|
2019 Effects of resistance-associated variants in genotype 2hepatitis C virus on viral replication and susceptibility to antihepatitis C virus drugs.
|
38 |
have revolutionised treatment for thehepatitis C virus
(1 time)
|
Health Services (1 time)
|
DAAs (1 time)
|
2018 Uptake of and Expenditure on Direct-Acting Antiviral Agents for Hepatitis C Treatment in Australia.
|
39 |
have suggested that ribavirin may potentiate the antihepatitis C virus
(1 time)
|
Allergy and Immunology (1 time)
|
IFN-alpha (1 time) IL (1 time)
|
2001 Treatment with ribavirin and interferon-alpha reduces interferon-gamma expression in patients with chronic hepatitis C.
|
40 |
HBsAg, antihepatitis C virus
(1 time)
|
Microbiology (1 time)
|
ANA (1 time) ASO (1 time) BP (1 time)
|
2020 Pediatric lupus nephritis - An evil cousin of its adult counterpart: A single-center based experience from a tertiary care hospital of Eastern India.
|
41 |
HCC in patients with chronic virus C
(1 time)
|
Natural Science Disciplines (1 time)
|
CHC (1 time) HCC (1 time) LC (1 time)
|
2022 Serum Folate deficiency in HCV related Hepatocellular Carcinoma.
|
42 |
HCV and ALD for F1-2, F3 and F4
(1 time)
|
Gastroenterology (1 time)
|
ALD (1 time) LS (1 time)
|
2015 Inflammation-adapted liver stiffness values for improved fibrosis staging in patients with hepatitis C virus and alcoholic liver disease.
|
43 |
HCV and cirrhosis remained significant contributors to greater spending
(1 time)
|
Gastroenterology (1 time)
|
---
|
2019 Prevalence, mortality and healthcare utilization among Medicare beneficiaries with Hepatitis C in Haemodialysis units.
|
44 |
HCV cohort
(1 time)
|
Virology (1 time)
|
aHR (1 time) AMD (1 time) CIs (1 time)
|
2021 Increased Risk of Age-Related Macular Degeneration with Chronic Hepatitis C Virus Infection: A Nationwide Population-Based Propensity Score-Matched Cohort Study in Taiwan.
|
45 |
HCV coinfected patients tend to develop hepatitis C
(1 time)
|
Allergy and Immunology (1 time)
|
---
|
2011 CXCR3 Expression Elevated on Peripheral CD8(+) Lymphocytes from HIV/HCV Coinfected Individuals.
|
46 |
HCV infections in 2015 in Japan was 1,905,187-2,490,873
(1 time)
|
|
NDB (1 time)
|
2022 Burden of chronic hepatitis B and C infections in 2015 and future trends in Japan: A simulation study.
|
47 |
HCV mono-infected
(1 time)
|
Allergy and Immunology (1 time)
|
GrzB (1 time)
|
2015 Schistosome infection aggravates HCV-related liver disease and induces changes in the regulatory T-cell phenotype.
|
48 |
HCV provider
(1 time)
|
Gastrointestinal Diseases (1 time)
|
CI (1 time) DAAs (1 time) FQHC (1 time)
|
2023 Barriers to Hepatitis C Virus Care and How Federally Qualified Health Centers Can Improve Patient Access to Treatment.
|
49 |
HCV pseudotypes VSVdeltaG
(1 time)
|
Allergy and Immunology (1 time)
|
VSV (1 time)
|
2005 Efficient formation of vesicular stomatitis virus pseudotypes bearing the native forms of hepatitis C virus envelope proteins detected after sonication.
|
50 |
HCV related cirrhosis
(1 time)
|
Neurology (1 time)
|
HCC (1 time) JCV (1 time) PML (1 time)
|
2016 Progressive Multifocal Leukoencephalopathy in a HIV Negative, Immunocompetent Patient.
|
51 |
HCV RNA positive
(1 time)
|
Biological Science Disciplines (1 time)
|
HIV (1 time) PWID (1 time)
|
2021 Role of direct and indirect social and spatial ties in the diffusion of HIV and HCV among people who inject drugs: a cross-sectional community-based network analysis in New Delhi, India.
|
52 |
HCV RNA undetectable
(1 time)
|
Neoplasms (1 time)
|
AEs (1 time) HBV (1 time) HCC (1 time)
|
2022 Low-dose nivolumab in advanced hepatocellular carcinoma.
|
53 |
HCV RNA-negative
(1 time)
|
Communicable Diseases (1 time)
|
aIRR (1 time) CI (1 time) CVD (1 time)
|
2019 Clinical Outcomes in Persons Coinfected With Human Immunodeficiency Virus and Hepatitis C Virus: Impact of Hepatitis C Virus Treatment.
|
54 |
HCV without signs/symptoms of lymphoproliferations/autoimmunity
(1 time)
|
Hematology (1 time)
|
BAFF-R (1 time) CV (1 time) HCV-CV (1 time)
|
2022 B-cell activating factor (BAFF), BAFF promoter and BAFF receptor allelic variants in hepatitis C virus related Cryoglobulinemic Vasculitis and Non-Hodgkin's Lymphoma.
|
55 |
HCV-Hun
(1 time)
|
Complementary Therapies (1 time)
|
---
|
1993 [Molecular cloning and sequencing of hepatitis C virus gene from human blood].
|
56 |
HCV-O strain
(1 time)
|
Biochemistry (1 time)
|
IFN (1 time) sO (1 time)
|
2005 Efficient replication of a full-length hepatitis C virus genome, strain O, in cell culture, and development of a luciferase reporter system.
|
57 |
HCV-related
(1 time)
|
Substance-Related Disorders (1 time)
|
CALD (1 time) HBV (1 time)
|
2002 Hepatocyte proliferation and apoptosis in relation to oxidative damage in alcohol-related liver disease.
|
58 |
HCV-titer
(1 time)
|
Substance-Related Disorders (1 time)
|
ALD (1 time)
|
1993 Effects of alcohol on the replication of hepatitis C virus.
|
59 |
HCV-transmission, evidence is provided that TO.FE
(1 time)
|
Virology (1 time)
|
---
|
2007 Molecular and cellular determinants of cell-to-cell transmission of HCV in vitro.
|
60 |
HCV-treated cohort
(1 time)
|
Virology (1 time)
|
CI (1 time) HR (1 time) IFN (1 time)
|
2021 Analysis of Different Types of Interferon-Associated Retinopathy in Patients with Chronic Hepatitis C Virus Infection Treated with Pegylated Interferon Plus Ribavirin.
|
61 |
HCV/ALD
(1 time)
|
Gastrointestinal Diseases (1 time)
|
ALD (1 time) LT (1 time) NASH (1 time)
|
2020 Nonalcoholic Steatohepatitis Becomes the Leading Indication for Liver Transplant Registrants Among US Adults Born Between 1945 and 1965.
|
62 |
HCVcAg
(1 time)
|
Clinical Laboratory Techniques (1 time)
|
EIA (1 time)
|
2001 Performance of a conventional enzyme immunoassay for hepatitis C virus core antigen in the early phases of hepatitis C infection.
|
63 |
HCVcc-Luc
(1 time)
|
Drug Therapy (1 time)
|
DAAs (1 time)
|
2016 Evaluation of antiviral drug synergy in an infectious HCV system.
|
64 |
HCVcoreAg protein
(1 time)
|
|
AFM (1 time)
|
2019 Detection of Hepatitis C Virus Core Protein in Serum Using Aptamer-Functionalized AFM Chips.
|
65 |
healthcare visit
(1 time)
|
Medicine (1 time)
|
CMC (1 time) IR (1 time) IRR (1 time)
|
2020 Healthcare trajectory of children with rare bone disease attending pediatric emergency departments.
|
66 |
heel velocity
(1 time)
|
Nervous System Diseases (1 time)
|
RCOF (1 time)
|
2013 Asymmetrical slip propensity: required coefficient of friction.
|
67 |
Hematocrit level
(1 time)
|
Clinical Medicine (1 time)
|
NBT (1 time) PV (1 time)
|
2015 The response of New-season Nile tilapia to Aeromonas hydrophila vaccine.
|
68 |
hepacivirus C virus
(1 time)
|
Virology (1 time)
|
BovHepV (1 time)
|
2019 Presence of a Novel Subtype of Bovine Hepacivirus in China and Expanded Classification of Bovine Hepacivirus Strains Worldwide into 7 Subtypes.
|
69 |
heparin correlation value
(1 time)
|
Hospitals (1 time)
|
APTT (1 time)
|
2011 Substitution of a heparin correlation value for activated partial thromboplastin time in heparin nomograms.
|
70 |
hepatic failure related to C virus
(1 time)
|
Microbiology (1 time)
|
CT (1 time)
|
1998 Efficacy of a short-term amphotericin B + flucytosine combination therapy followed by itraconazole monotherapy in acute and chronic AIDS-associated cryptococcosis.
|
71 |
hepatitis A virus, C virus
(1 time)
|
Gastroenterology (1 time)
|
ALT (1 time) anti-HCV (1 time) HBsAg (1 time)
|
1998 Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis.
|
72 |
hepatitis and discovery of the pathogen
(1 time)
|
|
---
|
2020 Hepatitis C: milestones from discovery to clinicalcure.
|
73 |
hepatitis B and/or C viruses
(1 time)
|
Acquired Immunodeficiency Syndrome (1 time)
|
CLD (1 time)
|
2006 Severe liver disease associated with prolonged exposure to antiretroviral drugs.
|
74 |
Hepatitis C is a blood-borne virus
(1 time)
|
Medicine (1 time)
|
EudraCT (1 time) IEPS (1 time) PWID (1 time)
|
2019 Randomised controlled trial conducted in injecting equipment provision sites to compare the effectiveness of different hepatitis C treatment regimens in people who inject drugs: A Direct obserVed therApy versus fortNightly CollEction study for HCV treatment-ADVANCE HCV protocol study.
|
75 |
hepatitis C virus associated cirrhosis
(1 time)
|
Gastroenterology (1 time)
|
ALc (1 time) ALcW (1 time) CC (1 time)
|
2011 Lack of association of primary iron overload and common HFE gene mutations with liver cirrhosis in adult Indian population.
|
76 |
Hepatitis C virus cases
(1 time)
|
Parasitology (1 time)
|
CMIR (1 time)
|
1999 Cell mediated immune response in chronic liver diseases: schistosomal, viral and neoplastic.
|
77 |
hepatitis C virus cirrhosis
(1 time)
|
Transplantation (1 time)
|
HCV-Ab (1 time) UNOS (1 time)
|
2006 No improvement in long-term liver transplant graft survival in the last decade: an analysis of the UNOS data.
|
78 |
hepatitis C virus related chronic hepatitis
(1 time)
|
Pathology (1 time)
|
CL (1 time)
|
2006 Liver infiltrating mononuclear cells in children with type 1 autoimmune hepatitis.
|
79 |
Hepatitis C Virus seropositive
(1 time)
|
Brain (1 time)
|
MDE (1 time)
|
2003 [Benefits of a preventive psychiatric accompaniment in patients Hepatitis C Virus seropositive (HCV): prospective study concerning 39 patients].
|
80 |
hepatitis C virus-related
(1 time)
|
Neoplasms (1 time)
|
HCC (1 time)
|
2019 Prognostic profile of patients with non-viral hepatocellular carcinoma: A comparative study with hepatitis C virus-related hepatocellular carcinoma using data mining analysis.
|
81 |
hepatitis C virus
(1 time)
|
Chemistry, Pharmaceutical (1 time)
|
HIV (1 time) TAM (1 time) VSV (1 time)
|
2019 Tamoxifen Protects from Vesicular Stomatitis Virus Infection.
|
82 |
hepatitis C-positive
(1 time)
|
Acquired Immunodeficiency Syndrome (1 time)
|
CSAT (1 time)
|
2007 A model of integrated primary care for HIV-positive patients with underlying substance use and mental illness.
|
83 |
hepatitis C-viremic donors to hepatitis C
(1 time)
|
Cardiac Surgical Procedures (1 time)
|
DAA (1 time)
|
2020 The impact of hepatitis C viremic donor lung allograft characteristics on post-transplantation outcomes.
|
84 |
hepatitis, is caused by a single-stranded RNA virus
(1 time)
|
Dentistry (1 time)
|
---
|
1996 Hepatitis C virus infection.
|
85 |
hepatocellular virus
(1 time)
|
Molecular Biology (1 time)
|
DAB (1 time) HCC (1 time)
|
2018 Purinoceptor expression in hepatocellular virus (HCV)-induced and non-HCV hepatocellular carcinoma: an insight into the proviral role of the P2X4 receptor.
|
86 |
Hepatocellular volume
(1 time)
|
Medicine (1 time)
|
EVA (1 time) IHS (1 time) SBA (1 time)
|
1988 Determinants of hepatic function in liver cirrhosis in the rat. Multivariate analysis.
|
87 |
hepatotropic viruses, especially hepatitis virus C
(1 time)
|
Substance-Related Disorders (1 time)
|
HCC (1 time)
|
2003 National survey of hepatocellular carcinoma in heavy drinkers in Japan.
|
88 |
hepatotropic viruses, hepatitis B and hepatitis C
(1 time)
|
Neoplasms (1 time)
|
HCC (1 time)
|
2006 Can therapy of hepatitis C affect the development of hepatocellular carcinoma?
|
89 |
high calorific value
(1 time)
|
Environmental Health (1 time)
|
BMP (1 time) FVW (1 time)
|
2017 Influence of chemical composition on biochemical methane potential of fruit and vegetable waste.
|
90 |
high case volume units
(1 time)
|
Gastrointestinal Diseases (1 time)
|
LCV (1 time) PUB (1 time)
|
2012 Management of peptic ulcer bleeding in different case volume workplaces: results of a nationwide inquiry in hungary.
|
91 |
High Contrast Visor
(1 time)
|
Aerospace Medicine (1 time)
|
LEP (1 time) SWAFs (1 time)
|
2000 Aircrew visors and color vision performance: a comparative and preliminary pilot study analysis.
|
92 |
high contrast volume
(1 time)
|
Complementary Therapies (1 time)
|
CI-AKI (1 time) CKD (1 time) MCV (1 time)
|
2015 Short-term rosuvastatin treatment for the prevention of contrast-induced acute kidney injury in patients receiving moderate or high volumes of contrast media: a sub-analysis of the TRACK-D study.
|
93 |
high-carbohydrate vegan
(1 time)
|
Dietetics (1 time)
|
DBS (1 time) HFPM (1 time)
|
2020 Postprandial Dried Blood Spot-Based Nutritional Metabolomic Analysis Discriminates a High-Fat, High-Protein Meat-Based Diet from a High Carbohydrate Vegan Diet: A Randomized Controlled Crossover Trial.
|
94 |
High-context-variability
(1 time)
|
Psychology (1 time)
|
LCV (1 time)
|
2007 The effect of context variability on source memory.
|
95 |
high-cut viscosity of whole blood
(1 time)
|
Complementary Therapies (1 time)
|
ACI (1 time) ADLs (1 time) ADRs (1 time)
|
2020 Clinical Efficacy of Tonic Traditional Chinese Medicine Injection on Acute Cerebral Infarction: A Bayesian Network Meta-Analysis.
|
96 |
high-cyanide cultivar
(1 time)
|
Physiology (1 time)
|
---
|
2002 Linamarase expression in cassava cultivars with roots of low- and high-cyanide content.
|
97 |
high-order cylindrical vector
(1 time)
|
Biophysics (1 time)
|
ACV (1 time) VHPs (1 time)
|
2021 Practical generation of arbitrary high-order cylindrical vector beams by cascading vortex half-wave plates.
|
98 |
HIV mono- and co-infected and hepatitis
(1 time)
|
Endocrinology (1 time)
|
IDUs (1 time)
|
2015 Serum adiponectin in HIV-1 and hepatitis C virus mono- and co-infected Kenyan injection drug users.
|
99 |
holdout cross-validation
(1 time)
|
Environmental Health (1 time)
|
LUR (1 time) PNC (1 time) UFP (1 time)
|
2021 High-Spatial-Resolution Estimates of Ultrafine Particle Concentrations across the Continental United States.
|
100 |
hollow cylinder volume
(1 time)
|
Ecological and Environmental Phenomena (1 time)
|
De (1 time) HA (1 time) HR (1 time)
|
2017 Internode morphometrics and allometry of Tonkin Cane Pseudosasa amabilis.
|